Suprathreshold field screeners are in common use for the detection of glaucomatous field loss. The predictive power of a positive result (PP+) depends on the sensitivity and specificity ofthe screener in the population in which it is to be used. Using data from 755 normal individuals (1510 eyes), we calculated the PP+ of the Henson CFS2000 screening programme for a population aged 50 and over. 4*3% of normal eyes failed the screening programme. Ignoring one or two misses on the screening programme immediately adjacent to the disc reduced this figure to 1*3% and significantly improved the PP+ of the programme. Calculations ofthe PP+ at increasing glaucoma prevalence levels indicates this to be particularly relevant at low levels such as those encountered when screening middle aged and elderly populations. Optometrists should perform routine field analysis when screening for glaucoma provided they adhere to strict protocols.
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indicates a true positive identification of the disease process and is related to both sensitivity and specificity.
To calculate the predictive power of the screening programme on the Henson CFS2000 in a population, the following data are required from that population: (a) the incidence of screen failures in normal persons; (b) the prevalence of field defects from other causes; (c) the prevalence of glaucomatous field loss; (d) the false negative rate on screening eyes with field loss from glaucoma.
If (c) remains a variable, the PP+ for each value of (c) can be calculated only if (a), (b), and (d) are known. (d) has been determined to be 10% in a sample of eyes representative of those presenting to a hospital department with glaucomatous field loss. ' Therefore in order to estimate the predictive power of the Henson CFS2000 screening programme in the field we analysed the data on normal persons and patients with non-glaucomatous field defects identified on screening a general practice population aged 50 and over.
The 26-point Henson CFS2000 screening programme has been formulated to provide maximum sensitivity and specificity when screening for glaucomatous field loss. In a study on 94 suspect eyes the programme's sensitivity and specificity were calculated to be 90% and 88% respectively.' If an eye fails the screening programme, the operator is required to 'extend', testing a total of 66 or 132 points. This might appear to suggest that 12% of 'normal' eyes will require an extended field.
Sensitivity, a measure of the false negatives, and specificity, a measure of the false positives, are dependent on the certainty that a subject is positive or negative for the condition and on the prevalence of the disease in the population in which the test is to be used. Neither of these parameters of the efficiency of a test can be extrapolated from a small group of patients under suspicion to the general population at risk from glaucoma. Although the sensitivity of the test can be estimated when the prevalence of the disease is high in a sample, the specificity cannot.
In a recent study of the methods employed by optometrists when screening for glaucoma almost 80% used visual field analysis, though usually only when either the disc appeared abnormal or the intraocular pressure (IOP) was raised.2
In practice, when screening an individual for glaucomatous field loss, the optometrist needs to know the predictive power of a positive test (PP+). It is the chance that a positive result
Material and methods
The population of a general practice aged 50 and over were invited by letter to attend for glaucoma screening: 874 people (88 5% of those invited) attended. They were screened by the following tests: intraocular pressures with a non-contact tonometer, optic disc assessment by an experienced ophthalmologist, and visual field analysis. The only exclusions from screening were a history of dementia, glaucoma, or blind registration. Computer analysis of the practice records revealed no significant difference between those who did and did not attend when the following variables were examined: age, sex, family history of glaucoma, known hypertension, or known diabetes.
Intraocular pressures were measured with the Keeler Pulsair non-contact tonometer; the mean of four readings per eye was taken. Visual field analysis was then performed with the Henson CFS2000 as described below, followed by optic disc assessment. All eyes were examined by, a single ophthalmologist (SAV) with a narrow beam direct ophthalmoscope through undilated pupils, discs being graded 'blind' as normal or suspicious. Any patient with an IOP >22 mmHg or having a suspicious optic disc was referred for a hospital assessment to determine the true status of the eye.
The visual fields were examined in the following manner with the screening programme of the Henson CFS2000: Results are presented in terms of eyes rather than patients because Henson's data reflecting the false negative rate for the screening programme relate to eyes only. However, only patients in whom both eyes were normal on all accounts could contribute to the normal data.
Calculations of predictive powers assume a 90% sensitivity for the screening programme.'
Results
The number of eyes attempting the field test was 1748 (874 patients, mean age 65 years). Twentyfive failed to detect the central target due to poor central acuity; therefore 1723 eyes were tested.
One hundred and thirteen eyes (6-56%) from 98 patients (mean age 65-2 years) required an extended test. Seven were diagnosed as suffering The PP+ ofthe Henson screening programme used in isolation in a population with a 1% ocular prevalence of glaucomatous field loss comprising 10000 eyes from persons aged 50 and over can be estimated as follows: 0 9% of 10000 will fail the screen because they do have glaucoma= 90. However, 6-15% of the 9900 non-glaucomatous eyes will also fail the screen=609.
PP+=
x 100 = 12-9%.
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This figure assumes any point missed at 0-5 log unit over threshold to be significant. The 95% CL are 11-1 to 15-4%.
If one or two misses immediately adjacent to the blind spot are considered insignificant, the PP+ at 1% glaucoma prevalence rises to 23-1% (95% CL 18-5 to 28-3%). Figure 1 shows the manner in which the PP+ of the Henson Some of the screening programme failures, with points missed around the disc, may be due to uncorrected optical errors producing artificial enlargement of the blind spot. The excess of left eyes in this group indicates that, unless left eyes in our unaided subjects had significantly greater optical errors, this effect is minimal. Other factors such as the method ofpadding the left eye during testing of the right eye may explain this phenomenon, but these cannot be determined from the results of this study.
Our study population is known to be representative of the population of Nottingham. Despite this, care should still be taken when interpreting the results. Alterations in any of the variables may have a profound effect on the PP+. In particular it is very dependent on a strict screening protocol being observed.
The prevalence of glaucomatous field loss is known to increase with age8 and in certain racial groups.9 Although the PP+ will always increase with a higher population prevalence of the disease, it will not do so in a linear manner. 
